Neuropeptide Y regulates osteocyte phenotype and function through AHNAK-Smad signalling

Area of Science:

• Bone Biology
• Cell Signaling
• Endocrinology

Background:

• Neuropeptide Y (NPY) is a hormone crucial for body homeostasis.
• Central NPY pathways influence bone metabolism.
• Osteocytes are a primary source of NPY within bone tissue.

Purpose of the Study:

• To investigate the role of osteocyte-derived NPY in bone cell function.
• To elucidate the molecular mechanisms underlying NPY's effects on osteocytes and osteoblasts.
• To identify novel interactions involving NPY in bone regulation.

Main Methods:

• Cell viability and proliferation assays.
• Analysis of NPY mRNA levels in osteocytes.
• Osteoblast mineralization assays using conditioned media.
• Co-immunoprecipitation to identify protein interactions.
• Western blotting to assess signaling pathway activation (p-Smad1/5/9).

Main Results:

• Osteocytic NPY significantly increased osteocyte viability and proliferation.
• Conditioned medium from NPY-overexpressing osteocytes enhanced osteoblast mineralization.
• The interaction between NPY and AHNAK was identified.
• NPY/AHNAK signaling influences p-Smad1/5/9 activation.
• NPY insufficiency decreased osteocytic proliferation and osteoblast marker expression, which was reversed by p-Smad1/5/9 activation.

Conclusions:

• Osteocytic NPY plays a direct role in regulating osteocyte phenotype and function.
• NPY influences osteoblast activity and mineralization.
• The NPY-AHNAK-Smad1/5/9 signaling axis represents a novel mechanism in bone regulation.
• These findings offer new perspectives for NPY-based therapeutic strategies for bone disorders.